1: Dong R, Yang R, Zhan Y, Lai HD, Ye CJ, Yao XY, Luo WQ, Cheng XM, Miao JJ, Wang JF, Liu BH, Liu XQ, Xie LL, Li Y, Zhang M, Chen L, Song WC, Qian W, Gao WQ, Tang YH, Shen CY, Jiang W, Chen G, Yao W, Dong KR, Xiao XM, Zheng S, Li K, Wang J. Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma. Cancer Cell. 2020 Nov 9;38(5):716-733.e6. doi: 10.1016/j.ccell.2020.08.014. Epub 2020 Sep 17. PMID: 32946775. 2: Meng L, Zhan Y, Wei M, Yang R, Wang J, Weng S, Chen L, Zheng S, Dong K, Dong R. Single-cell RNA sequencing of solid pseudopapillary neoplasms of the pancreas in children. Cancer Sci. 2023 May;114(5):1986-2000. doi: 10.1111/cas.15744. Epub 2023 Feb 16. PMID: 36721980; PMCID: PMC10154873. 3: Yang R, Zhan Y, Li Y, Dai SY, He SW, Ye CJ, Meng LD, Chen DQ, Dong CB, Chen L, Chen G, Dong KR, Li K, Zheng S, Li J, Yao W, Dong R. The Cellular and Molecular Landscape of Synchronous Pediatric Sialoblastoma and Hepatoblastoma. Front Oncol. 2022 Jul 4;12:893206. doi: 10.3389/fonc.2022.893206. PMID: 35860547; PMCID: PMC9289541. 4: Dai S, Gu Y, Zhan Y, Zhang J, Xie L, Li Y, Lu Y, Yang R, Zhou E, Chen D, Liu S, Zheng S, Shi Z, Dong K, Dong R. The potential mechanism of Aidi injection against neuroblastoma-an investigation based on network pharmacology analysis. Front Pharmacol. 2024 Jan 19;15:1310009. doi: 10.3389/fphar.2024.1310009. PMID: 38313313; PMCID: PMC10834740. 5: Ye M, Gao R, Chen S, Bai J, Chen J, Lu F, Gu D, Shi X, Yu P, Tian Y, Tang Q, Dong K. FAM201A encodes small protein NBASP to inhibit neuroblastoma progression via inactivating MAPK pathway mediated by FABP5. Commun Biol. 2023 Jul 12;6(1):714. doi: 10.1038/s42003-023-05092-7. PMID: 37438449; PMCID: PMC10338675. 6: Jiang S, Dong K, Li K, Liu J, Du X, Huang C, Jiao Y, Han Y, Yang J, Liao X, Li Y, Zhang T, Li S, Lv Z, Gao Y. Extracranial Germ Cell Tumors in Children: Ten Years of Experience in Three Children's Medical Centers in Shanghai. Cancers (Basel). 2023 Nov 14;15(22):5412. doi: 10.3390/cancers15225412. PMID: 38001671; PMCID: PMC10670163. 7: Wei M, Yang R, Ye M, Zhan Y, Liu B, Meng L, Xie L, Du M, Wang J, Gao R, Chen D, Dong R, Dong K. MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad/SNAI1 pathway. Am J Cancer Res. 2022 May 15;12(5):1960-1981. PMID: 35693071; PMCID: PMC9185624. 8: Ye M, Gao R, Chen S, Wei M, Wang J, Zhang B, Wu S, Xu Y, Wu P, Chen X, Ma J, Ma D, Dong K. Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression. J Cell Mol Med. 2022 Apr;26(8):2377-2391. doi: 10.1111/jcmm.17258. Epub 2022 Mar 8. PMID: 35257481; PMCID: PMC8995459. 9: Wang J, Wang Z, Lin W, Han Q, Yan H, Yao W, Dong R, Jia D, Dong K, Li K. LINC01296 promotes neuroblastoma tumorigenesis via the NCL-SOX11 regulatory complex. Mol Ther Oncolytics. 2022 Feb 15;24:834-848. doi: 10.1016/j.omto.2022.02.007. PMID: 35317520; PMCID: PMC8917274. 10: Ye Z, Qian L, Hu W, Miao S, Wang Y, Lu J, Zhou Y, Lu X, Zhang Y, Zheng C, Sun H, Tang W, Tang Z, Sun S, Dong K, Qian X, Zhai X, Huang Y. Clinical outcome of infantile-onset inflammatory bowel disease in 102 patients with interleukin-10 signalling deficiency. Aliment Pharmacol Ther. 2022 Jun;55(11):1414-1422. doi: 10.1111/apt.16837. Epub 2022 Feb 20. PMID: 35187668.